Company news

WuXi AppTec Co., Ltd. news in 2026

WuXi AppTec Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(603259)"Wuxi Apptec Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing

November 4, 2026

(603259)"Wuxi Apptec Co., Ltd."Report for Q3 2026

October 26, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

September 29, 2026

Announcement on Resolutions of the 6th Meeting of the 4th Board of Directors

September 21, 2026

WuXi Biologics Cayman: Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership

September 16, 2026

WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion

August 29, 2026

Announcement on Implementation of A-Share Dividend Distribution for the First Half of 2026

August 27, 2026

Announcement on Convening the 2026 Semi-annual Performance Briefing

August 20, 2026

Notice on Convening the 1st Extraordinary General Meeting in 2026

August 10, 2026

Voluntary Announcement

August 9, 2026

WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance, Driven by Greater Success of Multiple Customers’ Products and CRDMO Model

August 3, 2026

WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model

August 3, 2026

WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year

July 21, 2026

Announcement on Resolutions of the 4th Meeting of the 4th Board of Directors

July 1, 2026

Announcement on Implementation Results of Share Repurchase and Share Changes in 2026

June 26, 2026

Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Not Subject to Sales Restrictions Concerning A Share Repurchase

June 11, 2026

An open letter to our customers

June 8, 2026

Announcement on Implementation of Dividend Distribution for 2025

May 22, 2026

WuXi AppTec’s CRDMO Model: Linking Research, Development, and Manufacturing Across the Drug Development Lifecycle

May 18, 2026

WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index

May 17, 2026

WuXi AppTec Supports a More Connected Life Sciences Ecosystem Through Collaboration

April 30, 2026

Announcement on Resolutions of 2025 Annual General Meeting, the 1st A-shares General Meeting of 2026 and the 1st H-shares General Meeting of 2026

April 28, 2026

WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026

April 27, 2026

WXAT 2025 Annual Results Presentation

April 13, 2026

Announcement on Convening the 2025 Annual Performance Briefing

April 1, 2026

Notice on Convening the 2025 Annual General Meeting, the 1st Shareholders' Meeting of A Shares of 2026 and the 1st Shareholders' Meeting of H Shares of 2026

March 24, 2026

WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025

March 23, 2026

WuXi AppTec Receives Double 'A' Rating from CDP for Climate Change and Water Security Leadership

January 19, 2026

WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership

January 17, 2026

2026 JPM Presentation - WuXi AppTec 20260114

January 14, 2026

WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025

January 12, 2026

Announcement on Result of Shareholding Reduction by Shareholder

January 6, 2026

Calls in 2026

Decks in 2026